Sökning: onr:"swepub:oai:DiVA.org:uu-525417" >
Hypoalbuminemia, bu...
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy : A retrospective, cohort study of 557 patients
-
- Papantoniou, Dimitrios (författare)
- Uppsala universitet,Onkologisk endokrinologi,Ryhov Cty Hosp, Dept Oncol, Jönköping, Sweden.;Rudbecklab R3,2 Tr, S-75185 Uppsala, Sweden.
-
- Fröss-Baron, Katarzyna (författare)
- Uppsala universitet,Onkologisk endokrinologi
-
- Garske Roman, Ulrike, 1963- (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi
-
visa fler...
-
- Sundin, Anders, 1954- (författare)
- Uppsala universitet,Radiologi
-
- Thiis-Evensen, Espen (författare)
- Oslo Univ Hosp, Dept Transplantat Med, Rikshosp, Oslo, Norway.
-
- Grönberg, Malin, 1980- (författare)
- Uppsala universitet,Onkologisk endokrinologi
-
- Welin, Staffan (författare)
- Uppsala universitet,Onkologisk endokrinologi
-
- Tiensuu Janson, Eva (författare)
- Uppsala universitet,Onkologisk endokrinologi
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska.
-
Ingår i: Journal of neuroendocrinology. - : John Wiley & Sons. - 0953-8194 .- 1365-2826.
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Several inflammation scores have shown association with survival outcomes for patients with neuroendocrine tumours (NET) treated with peptide receptor radionuclide therapy (PRRT). However, whether these scores add value to established prognostic factors remains unknown. In this retrospective, cohort study of 557 NET patients undergoing PRRT in a tertiary referral centre from 2005 to 2015, we examined inflammatory markers and scores previously associated with cancer outcomes, using Cox proportional hazard models and Akaike's information criterion. Lower albumin (hazard ratio [95% confidence interval], .91 [.87-.95] per unit), as well as higher C-reactive protein (CRP; 1.02 [1.01-1.02]), Glasgow Prognostic Score (GPS; 1 vs. 0: 1.67 [1.14-2.44], 2 vs. 0 3.60 [2.24-5.79]), CRP/albumin ratio (1.84 [1.43-2.37]) and platelet count (Plt) x CRP, but not white blood cell, neutrophil and thrombocyte counts or derived neutrophil to lymphocyte ratio (dNLR), were associated with shorter median overall survival (OS) in an adjusted analysis. The addition of parameters based on albumin and CRP, but not dNLR, to a base model including age, chromogranin A, the cell proliferation marker Ki-67, performance status, tumour site and previous treatments improved the predictive accuracy of the base model. In an exploratory analysis of patients with available erythrocyte sedimentation rate (ESR) and CRP, ESR emerged as the most powerful predictor. When added to a prognostic model for OS in NET patients treated with PRRT, most inflammation scores further improved the model. Albumin was the single marker adding most value to the set of established prognostic markers, whereas dNLR did not seem to improve the model's prognostic ability.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- CRP
- dNLR
- hypoalbuminemia
- inflammatory markers
- neuroendocrine tumour
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Papantoniou, Dim ...
-
Fröss-Baron, Kat ...
-
Garske Roman, Ul ...
-
Sundin, Anders, ...
-
Thiis-Evensen, E ...
-
Grönberg, Malin, ...
-
visa fler...
-
Welin, Staffan
-
Tiensuu Janson, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Journal of neuro ...
- Av lärosätet
-
Uppsala universitet